Hologic (HOLX) Competitors

Hologic (NASDAQ:HOLX) and DexCom (NASDAQ:DXCM) are both large-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, dividends, valuation, profitability, risk, earnings, institutional ownership and media sentiment.

Which has more volatility and risk, HOLX or DXCM?

Hologic has a beta of 0.49, suggesting that its share price is 51% less volatile than the S&P 500. Comparatively, DexCom has a beta of 1.43, suggesting that its share price is 43% more volatile than the S&P 500.

Do analysts prefer HOLX or DXCM?

Hologic presently has a consensus target price of $78.00, indicating a potential upside of 14.54%. DexCom has a consensus target price of $99.90, indicating a potential upside of 23.10%. Given DexCom's stronger consensus rating and higher possible upside, analysts clearly believe DexCom is more favorable than Hologic.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Hologic	0 Sell rating(s)	8 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.59
DexCom	0 Sell rating(s)	4 Hold rating(s)	16 Buy rating(s)	3 Strong Buy rating(s)	2.96

Do institutionals & insiders have more ownership in HOLX or DXCM?

94.7% of Hologic shares are owned by institutional investors. Comparatively, 97.8% of DexCom shares are owned by institutional investors. 1.9% of Hologic shares are owned by insiders. Comparatively, 0.3% of DexCom shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Does the media favor HOLX or DXCM?

In the previous week, DexCom had 10 more articles in the media than Hologic. MarketBeat recorded 33 mentions for DexCom and 23 mentions for Hologic. Hologic's average media sentiment score of 1.47 beat DexCom's score of 1.27 indicating that Hologic is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Hologic	12 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
DexCom	24 Very Positive mention(s)	2 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Is HOLX or DXCM more profitable?

Hologic has a net margin of 13.79% compared to DexCom's net margin of 13.29%. DexCom's return on equity of 30.41% beat Hologic's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Hologic	13.79%	19.69%	10.82%
DexCom	13.29%	30.41%	10.08%

Which has higher earnings and valuation, HOLX or DXCM?

Hologic has higher revenue and earnings than DexCom. Hologic is trading at a lower price-to-earnings ratio than DexCom, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Hologic	$4.04B	3.75	$789.50M	$2.41	28.26
DexCom	$4.03B	7.89	$576.20M	$1.44	56.36

Summary

DexCom beats Hologic on 10 of the 17 factors compared between the two stocks.